CIK 0001191070 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Neuphoria Therapeutics Inc.
Sign in to watch- Ticker
- NEUP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- operating
- Phone
- 781-439-5551
- Business address
- 100 SUMMIT DR, BURLINGTON, MA, 01803
- Former names
- BIONOMICS LIMITED/FI
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-20 | Wilson David Ian Director | Grant or award · Restricted Stock Units | +8,537 | 15,412 | ||
| 2026-01-20 | Fisher Alan Director | Grant or award · Restricted Stock Units | +17,073 | 30,731 | ||
| 2026-01-20 | Davies Peter Miles Winston Director | Grant or award · Restricted Stock Units | +8,537 | 15,320 | ||
| 2026-01-20 | Ryan Jane Director | Grant or award · Restricted Stock Units | +8,537 | 15,550 | ||
| 2025-10-21 | Lynx1 Capital Management LP 10% owner | Purchase | +639,110 | $5.14 | $3.3M | 875,328 |
| 2025-08-27 | Papapetropoulos Spyros President and CEO | Grant or award · Employee Stock Option (Right-to- Buy) | +34,559 | $8.27 | $286K | 74,088 |
| 2025-04-16 | Papapetropoulos Spyros President and CEO | Grant or award · Employee Stock Option (Right-to-Buy) | +27,000 | $5.16 | $139K | 39,529 |
| 2025-04-16 | Papapetropoulos Spyros President and CEO | Grant or award · Employee Stock Option (Right-to-Buy) | +270,000 | $5.16 | $1.4M | 282,529 |
| 2025-04-16 | Davies Peter Miles Winston Director | Grant or award · Restricted Stock Units | +6,783 | 6,783 | ||
| 2025-04-16 | Ryan Jane Director | Grant or award · Restricted Stock Units | +6,783 | 7,013 | ||
| 2025-04-16 | Wilson David Ian Director | Grant or award · Restricted Stock Units | +6,783 | 6,875 | ||
| 2025-04-16 | Fisher Alan Director | Grant or award · Restricted Stock Units | +13,566 | 13,658 |
Page 1 of 1 · 12 trades